Filing Details

Accession Number:
0001596771-15-000068
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-27 17:04:12
Reporting Period:
2015-08-26
Filing Date:
2015-08-27
Accepted Time:
2015-08-27 17:04:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610092 Diplomat Pharmacy Inc. DPLO Retail-Drug Stores And Proprietary Stores (5912) 382063100
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1418307 Sean Whelan 4100 S. Saginaw Street
Flint MI 48507
Chief Financial Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-26 290,064 $4.29 292,064 No 4 M Direct
Common Stock Disposition 2015-08-26 119,852 $37.90 172,212 No 4 S Direct
Common Stock Disposition 2015-08-26 29,682 $38.60 142,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Option to Acquire Common Stock Disposition 2015-08-26 290,064 $0.00 290,064 $4.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
96,686 2022-03-01 No 4 M Direct
Footnotes
  1. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $37.48 to $38.33 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
  2. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $38.40 to $38.98 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
  3. The options were granted on 03/01/2012 and began to vest in annual increments of 25% of the option grant on the one-year anniversary of the date of grant, to be fully vested after four years. The remaining 96,686 options vest on 03/01/2016.